Cerebral amyloid angiopathy
- 3 November 2026
- journal article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Abstract
Cerebral amyloid angiopathy (CAA) is characterized by beta-amyloid deposition within cerebral blood vessels and constitutes an age-related vascular pathology associated with intracerebral hemorrhages and cognitive impairment. CAA is a major contributor to a subtype of stroke with high mortality, morbidity, and recurrence rates. The sporadic, familial, and iatrogenic variants of CAA have distinct epidemiological profiles. Inflammatory mechanisms exacerbate amyloid-induced vascular injury and may cause a distinct subtype of CAA-related inflammation. In 2022, an international collaborative study updated and validated the Boston Diagnostic Criteria (Version 2.0) for CAA across the full spectrum of clinical manifestations. Cognitive impairment in CAA generally manifests in three types: gradual functional decline, stepwise functional decline, and rapidly progressive cognitive deterioration associated with inflammation. CAA is strongly associated with Alzheimer’s disease (AD). While both conditions involve amyloid-β (Aβ) accumulation, their anatomical distributions differ. In AD, Aβ deposits mostly in the frontal and parietal association cortices. CAA is observed in approximately 90% of AD cases, and the coexistence of AD and CAA correlates with more severe disease progression.Keywords
This publication has 62 references indexed in Scilit:
- Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer DiseaseJAMA, 2026
- Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma BiomarkersJAMA Network Open, 2025
- The connection between cerebral amyloid angiopathy and Alzheimer’s diseaseEuropean Radiology, 2023
- Models of cerebral amyloid angiopathy-related intracerebral hemorrhageBrain Hemorrhages, 2022
- Cerebral amyloid angiopathy and related inflammatory disordersJournal of the Neurological Sciences, 2021
- Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumabAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
- Clinical pathologic case report: A 70-year-old man with inflammatory cerebral amyloid angiopathy causing headache, cognitive impairment, and aphasiaJournal of Clinical Neuroscience, 2018
- Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s diseaseActa Neuropathologica, 2016
- Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy–Related InflammationJAMA Neurology, 2016
- Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcomeNeuroradiology, 2014